Cite

HARVARD Citation

    Selinger, C. et al. (2017). Infliximab Therapeutic Drug Monitoring Changes Clinical Decisions in a Virtual Biologics Clinic for Inflammatory Bowel Disease. Inflammatory bowel diseases. 23 (12), p. . [Online]. 
  
Back to record